Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma - PubMed (original) (raw)
Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma
A H S Lee et al. Eur J Cancer. 2006 Feb.
Abstract
This study aimed to test the hypothesis that lymphovascular invasion adds prognostic information to histological grade and tumour size in node-negative invasive carcinoma of the breast. Lymphovascular invasion was assessed in haematoxylin and eosin tumour sections from 2760 patients with node-negative invasive breast carcinoma treated with definitive surgery. Patients were divided into two groups: 990 in the no adjuvant therapy series (diagnosed in 1974-1988) with median follow-up of 13 years; and 1765 in the selective adjuvant therapy series (1988-2000) with median follow-up of 6.8 years. Lymphovascular invasion was identified in 19% of tumours and was associated with larger tumour size, higher histological grade and younger age. Overall, survival was associated on multivariate analysis with lymphovascular invasion, histological grade and tumour size in both patient series, and with histological type in the no adjuvant therapy series. In conclusion, lymphovascular invasion is an independent prognostic factor in node-negative breast cancer and should be considered in decisions about adjuvant treatment in this group of women.
Similar articles
- Lymphovascular invasion is associated with reduced locoregional control and survival in women with node-negative breast cancer treated with mastectomy and systemic therapy.
Truong PT, Yong CM, Abnousi F, Lee J, Kader HA, Hayashi A, Olivotto IA. Truong PT, et al. J Am Coll Surg. 2005 Jun;200(6):912-21. doi: 10.1016/j.jamcollsurg.2005.02.010. J Am Coll Surg. 2005. PMID: 15922205 - Population-based study of peritumoral lymphovascular invasion and outcome among patients with operable breast cancer.
Ejlertsen B, Jensen MB, Rank F, Rasmussen BB, Christiansen P, Kroman N, Kvistgaard ME, Overgaard M, Toftdahl DB, Mouridsen HT; Danish Breast Cancer Cooperative Group. Ejlertsen B, et al. J Natl Cancer Inst. 2009 May 20;101(10):729-35. doi: 10.1093/jnci/djp090. Epub 2009 May 12. J Natl Cancer Inst. 2009. PMID: 19436035 - Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system.
Kahn HJ, Hanna WM, Chapman JA, Trudeau ME, Lickley HL, Mobbs BG, Murray D, Pritchard KI, Sawka CA, McCready DR, Marks A. Kahn HJ, et al. Breast J. 2006 Jul-Aug;12(4):294-301. doi: 10.1111/j.1075-122X.2006.00267.x. Breast J. 2006. PMID: 16848838 - Prognosis and management of patients with node-negative invasive breast carcinoma that is 1 cm or smaller in size (stage 1; T1a,bN0M0): a review of the literature.
Hanrahan EO, Valero V, Gonzalez-Angulo AM, Hortobagyi GN. Hanrahan EO, et al. J Clin Oncol. 2006 May 1;24(13):2113-22. doi: 10.1200/JCO.2005.02.8035. J Clin Oncol. 2006. PMID: 16648513 Review. - 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Di Saverio S, Catena F, Santini D, Ansaloni L, Fogacci T, Mignani S, Leone A, Gazzotti F, Gagliardi S, De Cataldis A, Taffurelli M. Di Saverio S, et al. Breast Cancer Res Treat. 2008 Jun;109(3):405-16. doi: 10.1007/s10549-007-9668-7. Epub 2007 Aug 9. Breast Cancer Res Treat. 2008. PMID: 17687650 Review.
Cited by
- A Nomogram for Predicting Lymphovascular Invasion in Superficial Esophageal Squamous Cell Carcinoma.
Ruan R, Chen S, Tao Y, Yu J, Zhou D, Cui Z, Shen Q, Wang S. Ruan R, et al. Front Oncol. 2021 May 10;11:663802. doi: 10.3389/fonc.2021.663802. eCollection 2021. Front Oncol. 2021. PMID: 34041028 Free PMC article. - The prognostic significance of lymphovascular invasion in patients with resectable gastric cancer: a large retrospective study from Southern China.
Li P, He HQ, Zhu CM, Ling YH, Hu WM, Zhang XK, Luo RZ, Yun JP, Xie D, Li YF, Cai MY. Li P, et al. BMC Cancer. 2015 May 7;15:370. doi: 10.1186/s12885-015-1370-2. BMC Cancer. 2015. PMID: 25947284 Free PMC article. - Nomogram-derived prediction of pathologic complete response (pCR) in breast cancer patients treated with neoadjuvant chemotherapy (NCT).
Pu S, Wang K, Liu Y, Liao X, Chen H, He J, Zhang J. Pu S, et al. BMC Cancer. 2020 Nov 19;20(1):1120. doi: 10.1186/s12885-020-07621-7. BMC Cancer. 2020. PMID: 33213397 Free PMC article. - Prognostic factors and recurrence in breast cancer: experience at the national cancer institute of Mexico.
Stankov A, Bargallo-Rocha JE, Silvio AÑ, Ramirez MT, Stankova-Ninova K, Meneses-Garcia A. Stankov A, et al. ISRN Oncol. 2012;2012:825258. doi: 10.5402/2012/825258. Epub 2012 Jul 5. ISRN Oncol. 2012. PMID: 22830047 Free PMC article. - Prognostic and predictive factors and genetic analysis of early breast cancer.
Martín M, González Palacios F, Cortés J, de la Haba J, Schneider J. Martín M, et al. Clin Transl Oncol. 2009 Oct;11(10):634-42. doi: 10.1007/s12094-009-0418-7. Clin Transl Oncol. 2009. PMID: 19828405 Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical